Bhanu Visvalingam
Medical Oncology · Orange City, FLNPI 1336132844
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.7%), gifts and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Tosoh Bioscience, Inc. at 35.5% of the total. Reporting peaked in 2019 at $25,818 and has fallen 92.1% since, to $2,043 in 2025.
Across 142 payments — averaging $214.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tosoh Bioscience, Inc.$11K
- Bristol Myers Squibb$7K
- Gilead$5K
- AstraZeneca$4K
- Daiichi Sankyo Inc.$799
- Astrazeneca UK Limited$723
- plus $2K from 31 others
Across 114 payments — averaging $7831.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$747K
- Secura Bio, Inc.$55K
- Verastem, Inc.$31K
- Pfizer$22K
- AstraZeneca$18K
- Regeneron$10K
- plus $10K from 2 others
What the payments were for
- Consulting fees$12,70842%
- Speaking & faculty fees$3601%
- Travel & lodging$2,94010%
- Food & beverage$3,64812%
- Gifts$10,81235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tosoh Bioscience, Inc. | 4 | $10,812 |
| Bristol Myers Squibb | 13 | $7,300 |
| Gilead(2 entities) | 16 | $4,918 |
| AstraZeneca(2 entities) | 10 | $3,830 |
| Daiichi Sankyo Inc. | 9 | $799 |
| Astrazeneca UK Limited | 7 | $723 |
| Novartis | 10 | $244 |
| Pfizer | 8 | $188 |
| Genentech USA, Inc. | 2 | $163 |
| Exelixis Inc. | 2 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $145 |
| Astellas Pharma US Inc | 8 | $137 |
| Merck | 5 | $132 |
| Incyte Corporation | 5 | $102 |
| Johnson & Johnson | 4 | $81 |
| AbbVie | 3 | $73 |
| Lilly USA, LLC | 2 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Echosens North America, Inc. | 1 | $50 |
| Dendreon Pharmaceuticals LLC | 2 | $48 |
| GSK | 2 | $47 |
| Pharmaand GmbH | 3 | $46 |
| Tolmar, Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Geron Corporation | 1 | $25 |
| Sobi, Inc | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $21 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $18 |
| EMD Serono, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| Springworks Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Luspatercept$7,114
- FOL, AIA-PACK, Calibrator Set$5,406
- ST AIA-PACK Cystatin C Calibrator Set$5,406
- Yescarta$4,592
- PA, ST AIA-PACK$2,703
- PA, AIA-PACK Calibrator Set$2,703
- CEA, ST, AIA-PACK$2,703
- CEA, AIA-PACK Calibrator Set$2,703
- TSH, ST AIA-PACK$2,703
- B12, AIA-PACK Calibrator Set$2,703
- B12, AIA-PACK Sample Diluting Solution$2,703
- FOL, AIA-PACK$2,703
- FOL, AIA-PACK, Sample Diluting Solution$2,703
- CEA, AIA-PACK Linearity Set$2,703
- PA, AIA-PACK Linearity Set$2,703
- Cystatin C, ST AIA-PACK$2,703
- TSH3G, AIA-PACK Calibrator Set$2,703
- CA19-9, ST AIA-PACK$2,703
- CA 19-9, Sample Diluting Solution$2,703
- B12, AIA-PACK$2,703
How this compares
$30,468 in reported general payments places this provider in the 80th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Orange City
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.